Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare® Expands Clinical Services for Patients Enrolled in Medicare Advantage
Starting with a large multi-state health plan, TRHC’s SinfoniaRx® solution will begin providing medication reviews and pain assessments for patients enrolled in Medicare Special Needs Plans (SNPs), one type of a Medicare Advantage plan. Medicare SNPs are supporting nearly 3.5 million Americans as of
“Managed care plans came to us for assistance in meeting quality medication review requirements,” said TRHC Executive Vice President
TRHC services to meet COA measures are delivered through TRHC’s RxCompanion™, a highly customizable and scalable platform that identifies and helps resolve medication and health-related problems. Through a population management approach, potential problems are triaged based on urgency and complexity, then resolved through telephonic, face-to-face or video-based consultations with a pharmacist.
“Patients in Medicare Special Needs Plans now can receive a personal medication list and medication action plan to help them better understand and maintain their medications,” said TRHC Chairman and CEO
This press release includes forward-looking statements that we believe to be reasonable as of today’s date. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. These forward-looking statements include, among other things, our goals and expectations regarding the combined company and the integration of PW into TRHC, the expected synergies from the combined company and the expected financial and operating performance of TRHC following the completion of the acquisition. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the risk that we may not be able to achieve our expectations for the combined companies due to challenges in integration and inability to retain key employees; fluctuations in our financial results; the acceptance and use of our products and services by PACE organizations and pharmacies; the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; our ability to maintain relationships with a specified drug wholesaler; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; the requirements of being a public company; our ability to recognize the expected benefits from acquisitions on a timely basis or at all; and the other risk factors set forth from time to time in our filings with the
T: (215) 870-0829
T: (866) 648-2767
T: (856) 912-5714
Source: Tabula Rasa HealthCare, Inc.